Robust de novo design of protein binding proteins from target structural information alone
Cao, L.; Coventry, B.; Goreshnik, I.; Huang, B.; Park, J. S.; Jude, K. M.; Markovic, I.; Kadam, R. U.; Verschueren, K. H. G.; Verstraete, K.; Walsh, S. T. R.; Bennett, N.; Phal, A.; Yang, A.; Kozodoy, L.; DeWitt, M.; Picton, L.; Miller, L.; Strauch, E.-M.; Halabiya, S.; Hammerson, B.; Yang, W.; Benard, S.; Stewart, L.; Wilson, I. A.; Ruohola-Baker, H.; Schlessinger, J.; Lee, S.; Savvides, S. N.; Garcia, K. C. N.; Baker, D.
Show abstract
The design of proteins that bind to a specific site on the surface of a target protein using no information other than the three-dimensional structure of the target remains an outstanding challenge. We describe a general solution to this problem which starts with a broad exploration of the very large space of possible binding modes and interactions, and then intensifies the search in the most promising regions. We demonstrate its very broad applicability by de novo design of binding proteins to 12 diverse protein targets with very different shapes and surface properties. Biophysical characterization shows that the binders, which are all smaller than 65 amino acids, are hyperstable and bind their targets with nanomolar to picomolar affinities. We succeeded in solving crystal structures of four of the binder-target complexes, and all four are very close to the corresponding computational design models. Experimental data on nearly half a million computational designs and hundreds of thousands of point mutants provide detailed feedback on the strengths and limitations of the method and of our current understanding of protein-protein interactions, and should guide improvement of both. Our approach now enables targeted design of binders to sites of interest on a wide variety of proteins for therapeutic and diagnostic applications.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Atomically accurate de novo design of antibodies with RFdiffusion 99%
- Cryptochrome-Timeless structure reveals circadian clock timing mechanisms 98%
- Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies 98%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.